Bat guano as new and attractive chitin and chitosan source

WOS: 000340918700001Introduction: Chitin is a biopolymer that forms the exoskeleton of arthropods, and is found in the cell walls of fungi. It has a wide range of uses in fields such as cosmetics, pharmacy, medicine, bioengineering, agriculture, textiles and environmental engineering based upon its nontoxic, ecofriendly, biocompability and biodegradability characteristics. Commercially, chitin is obtained from processing the outer skeleton of Crustacea such as shrimp, crab, prawn and crayfish after they have been consumed as food. The study aims to examine the nature of bat guano and to determine if it is a practical source of chitin, which has not been done previously. Results: In this study, the chitin content of dry bat guano samples was found to be 28%. The bat guano, which was collected from Karacamal Cave, came from the bat species Rhinolophus hipposideros. The chitosan yield of this chitin was 79%. The chitin produced from the bat guano was determined to be in the alpha form according to Fourier transform infrared spectroscopy (FTIR) results. The crystallinity of the chitin and chitosan samples was calculated as 85.49 and 58.51% respectively by X-ray crystallography (XRD) experiments. According to scanning electron microscope (SEM) micrographs, the chitin and chitosan structures were shaped like nanofibers. The thermogravimetric analysis (TGA) results showed that both chitin and chitosan had two step weight losses, which are characteristic of these materials. The nitrogen content of the chitin and chitosan was 6.47 and 7.3% respectively according to the elemental analysis results. Conclusions: In this research, it has been observed that bat guano can be considered to be an alternative source of chitin and chitosan to crab, shrimp, crayfish and krill.Aksaray University BAP [2014-005]We would like to thank Prof. Dr. Ahmet KARATAS for bat species identification. This study was funded by Aksaray University BAP (2014-005)

Simultaneous Detection of Major Drug Resistance Mutations in the Protease and Reverse Transcriptase Genes for HIV-1 Subtype C by Use of a Multiplex Allele-Specific Assay

High-throughput, sensitive, and cost-effective HIV drug resistance (HIVDR) detection assays are needed for large-scale monitoring of the emergence and transmission of HIVDR in resource-limited settings. Using suspension array technology, we have developed a multiplex allele-specific (MAS) assay that can simultaneously detect major HIVDR mutations at 20 loci. Forty-five allele-specific primers tagged with unique 24-base oligonucleotides at the 5′ end were designed to detect wild-type and mutant alleles at the 20 loci of HIV-1 subtype C. The MAS assay was first established and optimized with three plasmid templates (C-wt, C-mut1, and C-mut2) and then evaluated using 148 plasma specimens from HIV-1 subtype C-infected individuals. All the wild-type and mutant alleles were unequivocally distinguished with plasmid templates, and the limits of detection were 1.56% for K219Q and K219E, 3.13% for L76V, 6.25% for K65R, K70R, L74V, L100I, K103N, K103R, Q151M, Y181C, and I47V, and 12.5% for M41L, K101P, K101E, V106A, V106M, Y115F, M184V, Y188L, G190A, V32I, I47A, I84V, and L90M. Analyses of 148 plasma specimens revealed that the MAS assay gave 100% concordance with conventional sequencing at eight loci and >95% (range, 95.21% to 99.32%) concordance at the remaining 12 loci. The differences observed were caused mainly by 24 additional low-abundance alleles detected by the MAS assay. Ultradeep sequencing analysis confirmed 15 of the 16 low-abundance alleles. This multiplex, sensitive, and straightforward result-reporting assay represents a new efficient genotyping tool for HIVDR surveillance and monitoring